Top Suppliers:I want be here

1403894-72-3

1403894-72-3 structure
1403894-72-3 structure
  • Name: Mesdopetam
  • Chemical Name: N-{2-[3-Fluoro-5-(methylsulfonyl)phenoxy]ethyl}-1-propanamine
  • CAS Number: 1403894-72-3
  • Molecular Formula: C12H18FNO3S
  • Molecular Weight: 275.34
  • Catalog: Signaling Pathways GPCR/G Protein Dopamine Receptor
  • Create Date: 2021-12-20 17:32:48
  • Modify Date: 2025-08-28 08:24:19
  • Mesdopetam (IRL790) is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties. Mesdopetam is used for the research of motor and psychiatric complications in Parkinson disease[1][2].

Name N-{2-[3-Fluoro-5-(methylsulfonyl)phenoxy]ethyl}-1-propanamine
Synonyms 1-Propanamine, N-[2-[3-fluoro-5-(methylsulfonyl)phenoxy]ethyl]-
N-{2-[3-Fluoro-5-(methylsulfonyl)phenoxy]ethyl}-1-propanamine
Description Mesdopetam (IRL790) is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties. Mesdopetam is used for the research of motor and psychiatric complications in Parkinson disease[1][2].
Related Catalog
Target

D3 Receptor

In Vivo Mesdopetam (IRL790) (3.7, 11, 33, or 100 µmol/kg) dose-dependently inhibits the behavioral activation following pretreatment with D-amphetamine or MK-80[1]. Mesdopetam (10 mg/kg; intraperitoneally; fourteen-week-old male C57BL/J mice) promotes a sedative effect similar to haloperidol with significantly reduced total distance traveled and reduced average speed[2]. Animal Model: Male Sprague-Dawley rats[1] Dosage: 3.7, 11, 33, or 100 µmol/kg (synthesized in-house as HCl salt, was dissolved in physiologic saline (0.9% w/v NaCl) Administration: s.c. was administered subcutaneously 4 min before the start of recording Result: Dose-dependently inhibited the behavioral activation following pretreatment with D-amphetamine or MK-801.
References

[1]. Waters S, et al. Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. J Pharmacol Exp Ther. 2020;374(1):113-125.

[2]. Becanovic K, et al. Effects of a Novel Psychomotor Stabilizer, IRL790, on Biochemical Measures of Synaptic Markers and Neurotransmission. J Pharmacol Exp Ther. 2020;374(1):126-133.

Density 1.2±0.1 g/cm3
Boiling Point 428.5±45.0 °C at 760 mmHg
Molecular Formula C12H18FNO3S
Molecular Weight 275.34
Flash Point 212.9±28.7 °C
Exact Mass 275.099152
LogP 1.50
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.500
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.